An open access publishing programme by MakingLife
MakingPharmaIndustry Working Papers is an open access publishing initiative by MakingLife Srl, hosted on MakingPharmaIndustry, the digital platform focused on the pharmaceutical industry, life sciences, healthcare innovation and industrial transformation.
The series publishes analytical papers, research-informed contributions, industry reports, policy reflections and interdisciplinary studies on the evolution of the pharmaceutical and life sciences sectors.
Its purpose is to provide a structured, traceable and citable environment for high-quality editorial and research-informed content, supported by dedicated HTML pages, downloadable full-text PDFs, bibliographic metadata and DOI assignment through Zenodo, where available.
Scope
MakingPharmaIndustry Working Papers covers topics of strategic relevance to the pharmaceutical and life sciences ecosystem, including:
- pharmaceutical industry and market dynamics;
- life sciences innovation;
- regulatory affairs and healthcare policy;
- pharmaceutical manufacturing and supply chain;
- digital transformation and artificial intelligence;
- sustainability, ESG and industrial strategy;
- access, value and healthcare systems;
- organizational change and professional skills;
- emerging markets and global health scenarios.
The series is intended for industry professionals, researchers, consultants, policymakers, institutions and other stakeholders interested in the structural transformations shaping the future of pharma and life sciences.
Publication model
Each Working Paper is published in open access and includes:
- a dedicated HTML page;
- a downloadable full-text PDF;
- title, author information and affiliation;
- abstract and keywords;
- bibliographic references;
- recommended citation;
- DOI assigned through Zenodo, when available.
The series is designed to improve discoverability, citation and long-term accessibility of editorial and research-informed contributions published by MakingPharmaIndustry.
Editorial approach
MakingPharmaIndustry Working Papers adopts an editorial assessment model based on relevance, clarity, documentation, originality and consistency with the scope of the series.
Contributions are reviewed by the editorial office and, when appropriate, may also be assessed by external subject-matter experts. The review process is not intended to replace formal academic peer review unless explicitly stated for a specific paper.
Publisher
MakingPharmaIndustry Working Papers is published by:
MakingLife Srl
Publisher of MakingPharmaIndustry
Italy
Explore the series
Archive
Browse all published Working Papers.
Submissions
Read the instructions for authors and contributors.
Editorial Process
Discover how contributions are assessed and prepared for publication.
Publication Ethics
Read the principles on authorship, conflicts of interest, corrections and retractions.
Editorial Board
Learn more about the editorial structure of the series.
